Epigenetics and epilepsy

[1]  I. Blümcke,et al.  Deep sequencing reveals increased DNA methylation in chronic rat epilepsy , 2013, Acta Neuropathologica.

[2]  V. Haroutunian,et al.  Epigenetic determinants of healthy and diseased brain aging and cognition. , 2013, JAMA neurology.

[3]  M. Gos.  Epigenetic mechanisms of gene expression regulation in neurological diseases. , 2013, Acta neurobiologiae experimentalis.

[4]  Sanaa Choufani,et al.  Basic concepts of epigenetics. , 2013, Fertility and sterility.

[5]  R. Dingledine,et al.  Epigenetics and epilepsy , 2012, Epilepsia.

[6]  F. Lubin.  Epileptogenesis: Can the Science of Epigenetics Give Us Answers? , 2012, Epilepsy currents.

[7]  S. Haggarty,et al.  An epigenetic blockade of cognitive functions in the neurodegenerating brain , 2012, Nature.

[8]  R. Stallings,et al.  Differential DNA Methylation Patterns Define Status Epilepticus and Epileptic Tolerance , 2012, The Journal of Neuroscience.

[9]  Xue-feng Wang,et al.  Increased expression of histone deacetylases 2 in temporal lobe epilepsy: A study of epileptic patients and rat models , 2012, Synapse.

[10]  M. Fraga,et al.  Epigenetics and the environment: emerging patterns and implications , 2012, Nature Reviews Genetics.

[11]  R. Stallings,et al.  miRNA Expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132. , 2011, The American journal of pathology.

[12]  Xue-feng Wang,et al.  Increased Expression of DNA methyltransferase 1 and 3a in Human Temporal Lobe Epilepsy , 2011, Journal of Molecular Neuroscience.

[13]  Fumiaki Sato,et al.  MicroRNAs and epigenetics , 2011, The FEBS journal.

[14]  Yan Cheng,et al.  Temporal lobe epilepsy induces differential expression of hippocampal miRNAs including let-7e and miR-23a/b , 2011, Brain Research.

[15]  Li Feng,et al.  Expression profile of microRNAs in rat hippocampus following lithium–pilocarpine-induced status epilepticus , 2011, Neuroscience Letters.

[16]  Gary W. Mathern,et al.  Erratum: Definition of drug resistant epilepsy. Consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies (Epilepsia (2010) 51 (1069-77)) , 2010 .

[17]  M. Mehler,et al.  Epigenetic mechanisms underlying human epileptic disorders and the process of epileptogenesis , 2010, Neurobiology of Disease.

[18]  S. Skinner,et al.  Epilepsy and the natural history of Rett syndrome , 2010, Neurology.

[19]  F. Sharp,et al.  Brain and Blood microRNA Expression Profiling of Ischemic Stroke, Intracerebral Hemorrhage, and Kainate Seizures , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[20]  S. Moshé,et al.  Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies , 2009, Epilepsia.

[21]  Manel Esteller,et al.  Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies , 2009, The Lancet Neurology.

[22]  M. Hildebrandt,et al.  Increased Reelin Promoter Methylation Is Associated With Granule Cell Dispersion in Human Temporal Lobe Epilepsy , 2009, Journal of neuropathology and experimental neurology.

[23]  A. Feinberg.  Epigenetics at the epicenter of modern medicine. , 2008, JAMA.

[24]  S. Berger.  The complex language of chromatin regulation during transcription , 2007, Nature.

[25]  T. Kouzarides.  Chromatin Modifications and Their Function , 2007, Cell.

[26]  R. Feil,et al.  Environmental and nutritional effects on the epigenetic regulation of genes. , 2006, Mutation research.

[27]  Robin Holliday,et al.  Epigenetics: A Historical Overview , 2006, Epigenetics.

[28]  A. Beaudet,et al.  Angelman syndrome 2005: Updated consensus for diagnostic criteria , 2006, American journal of medical genetics. Part A.

[29]  E. Nestler,et al.  Histone Modifications at Gene Promoter Regions in Rat Hippocampus after Acute and Chronic Electroconvulsive Seizures , 2004, The Journal of Neuroscience.

[30]  J. Clayton-Smith,et al.  Angelman syndrome: a review of the clinical and genetic aspects , 2003, Journal of medical genetics.

[31]  R. Dingledine,et al.  Altered Histone Acetylation at Glutamate Receptor 2 and Brain-Derived Neurotrophic Factor Genes Is an Early Event Triggered by Status Epilepticus , 2002, The Journal of Neuroscience.

[32]  M. Frotscher,et al.  Role for Reelin in the Development of Granule Cell Dispersion in Temporal Lobe Epilepsy , 2002, The Journal of Neuroscience.

[33]  G. Hagberg,et al.  Epilepsy in a representative series of Rett syndrome , 2001, Acta paediatrica.

[34]  H. Zoghbi,et al.  Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.

[35]  R. Olsen,et al.  Angelman syndrome: Correlations between epilepsy phenotypes and genotypes , 1998, Annals of neurology.

[36]  D. Ledbetter,et al.  Is Angelman syndrome an alternate result of del(15)(q11q13)? , 1987, American journal of medical genetics.

[37]  A. Feinberg,et al.  Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.

[38]  R. Zukin,et al.  Epigenetic Mechanisms in Stroke and Epilepsy , 2013, Neuropsychopharmacology.

[39]  D. M. Fernández-Mayoralas,et al.  SINDROME DE RETT: 50 AÑOS DE HISTORIA DE UN TRASTORNO AUN NO BIEN CONOCIDO , 2007 .

[40]  T. Spector,et al.  From The Cover : Epigenetic differences arise during the lifetime of monozygotic twins , 2005 .

[41]  Marco Cerbón,et al.  Metilación del ADN: un fenómeno epigenético de importancia médica , 2004 .